US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 25.220
  • -0.060-0.24%
Close Feb 14 16:00 ET
  • 25.220
  • 0.0000.00%
Post 20:01 ET
693.57MMarket Cap-6.00P/E (TTM)

About LENZ Therapeutics Company

LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Solana Beach, CA.

Company Profile

SymbolLENZ
Company NameLENZ Therapeutics
Listing DateJun 25, 2021
Founded2013
CEOMr. Evert B. Schimmelpennink
MarketNASDAQ
Fiscal Year Ends12-31
Address201 Lomas Santa Fe Drive,Suite 300
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-7000
Websitehttp://www.lenz-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • Evert B. Schimmelpennink
  • Director, President, Chief Executive Officer and Secretary
  • --
  • Shawn Olsson
  • Chief Commercial Officer
  • --
  • Dr. Marc Odrich, M.D.
  • Chief Medical Officer
  • --
  • Daniel R. Chevallard
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Jeffrey P. George
  • Chairman of the Board
  • --
  • James McCollum, M.D.
  • Director
  • --
  • Dr. Frederic Guerard, Pharm.D.
  • Independent Director
  • --
  • Dr. Zachary Scheiner, PhD
  • Independent Director
  • --
  • Dr. Kimberlee Cobleigh Drapkin, PhD
  • Independent Director
  • --
  • Shelley B. Thunen
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?